Year archive

Valneva SE — 2013 filings

All 90 regulatory filings released by Valneva SE (VLA) in 2013, sourced directly from the official regulator.

90 Filings

2013 Period

2013 filings (90)

Filing	Released	Lang
2013_12_09 Valneva Financing PR FR Capital/Financing Update	2013-12-09	French
2013_12_09 Valneva Financing PR Capital/Financing Update	2013-12-09	English
Déclaration d’actions et de droits de vote – NOVEMBRE 2013 Declaration of Voting Results & Voting Rights Announcements	2013-12-04	French
2013_11_07Aeras+SSI TB FR Regulatory Filings	2013-11-08	French
2013_11_08 Aeras+SSI TB PR EN Regulatory Filings	2013-11-08	English
2013_11_05 ValnevaShares&Votingrights Declaration of Voting Results & Voting Rights Announcements	2013-11-05	French
2013_11_05 Valneva Q3 EN Interim / Quarterly Report Q3 2013	2013-11-05	English
2013811_05 Q3 Valneva FR Interim / Quarterly Report Q3 2013	2013-11-05	French
2013_10_30_Valneva IC43 PR_EN Regulatory Filings	2013-10-30	English
2013_10_30 Valneva IC43_PR FR Regulatory Filings	2013-10-30	French
2013_10_18 IXIARO PR EN Regulatory Filings	2013-10-18	English
2013_10_18 IXIARO PR FR Regulatory Filings	2013-10-18	French
2013_10_04ValnevaDeclarationActions Declaration of Voting Results & Voting Rights Announcements	2013-10-04	French
2013_10_02 Valneva IAVI PR FR Regulatory Filings	2013-10-02	French
2013_10_02 Valneva IAVI PR EN Regulatory Filings	2013-10-02	English
20130912ValnevaDeltaVirPRFR Regulatory Filings	2013-09-12	French
20130912ValnevaDeltaVirPREN M&A Activity	2013-09-12	English
Declaration actions et droits de vote aout 2013 Declaration of Voting Results & Voting Rights Announcements	2013-09-04	French
20130902IC84PRFR Regulatory Filings	2013-09-02	French
20130902IC84PREN Regulatory Filings	2013-09-02	English
Half Year Financial Report Interim / Quarterly Report H1 2013	2013-08-28	English
Rapport Financier Semestriel Interim / Quarterly Report H1 2013	2013-08-28	French
20130828ValnevaH1ResultsFR Interim / Quarterly Report H1 2013	2013-08-28	French
20130828ValnevaH1ResultsEN Interim / Quarterly Report H1 2013	2013-08-28	English
20130812MajidFRPR Board/Management Information	2013-08-12	French
20130812MajidENPR Board/Management Information	2013-08-12	English
VALNEVA ACTIONS ET DROITS DE VOTE 2013 Declaration of Voting Results & Voting Rights Announcements	2013-08-06	French
20130722BEValnevaPREN Regulatory Filings	2013-07-22	English
20130722BEValnevaPRFR Regulatory Filings	2013-07-22	French
VALNEVA ACTIONS ET DROITS DE VOTE JUILLET 2013 Declaration of Voting Results & Voting Rights Announcements	2013-07-19	French
20130716ENValnevaBIVPR Regulatory Filings	2013-07-16	English
20130716FRValnevaBIVPR M&A Activity	2013-07-16	French
VALNEVA : Contrat de liquidité Bilan semestriel Regulatory Filings	2013-07-05	French
VALNEVA :DECLARATIONS ACTIONS ET DROITS DE VOTE Declaration of Voting Results & Voting Rights Announcements	2013-07-05	French
Share Issue/Capital Change 2013 Share Issue/Capital Change	2013-07-04	English
Share Issue/Capital Change 2013 Share Issue/Capital Change	2013-07-04	German
Valneva announces the successful completion of its €40 million capital increase - transaction was oversubscribed by 146%. Share Issue/Capital Change	2013-07-04	English
Valneva annonce le succès de son augmentation de capital de €40 millions - opération sursouscrite à 146% Share Issue/Capital Change	2013-07-04	French
Le Centre américain de Contrôle et de prévention des maladies (CDC) étend l'utilisation du vaccin IXIARO® Regulatory Filings	2013-06-21	French
ACIP Unanimously Votes to Extend the Recommendations for Use of IXIARO®Vaccine Environmental & Social Information	2013-06-21	English
Regulatory Filings 2013 Regulatory Filings	2013-06-21	English
Share Issue/Capital Change 2013 Share Issue/Capital Change	2013-06-13	German
Share Issue/Capital Change 2013 Share Issue/Capital Change	2013-06-13	English
Valneva annonce le lancement d'une augmentation de capital, garantie intégralement, avec maintien du droit préférentiel de souscription d'un montant de 40 millions d'euros Share Issue/Capital Change	2013-06-13	French
Valneva announces launch of a fully underwritten €40 million capital increase with preferential subscription rights Capital/Financing Update	2013-06-13	English
VALNEVA : ACTIONS ET DROITS DE VOTE MAI 2013 Declaration of Voting Results & Voting Rights Announcements	2013-06-10	French
Valneva SE announces the sale of its Clinical Manufacturing Operations (CMO) in France to Biological E M&A Activity	2013-06-07	English
Valneva SE annonce la cession de son activité française de bioproduction à la société Biological E M&A Activity	2013-06-07	French
Share Issue/Capital Change 2013 Share Issue/Capital Change	2013-05-28	English
M&A Activity 2013 M&A Activity	2013-05-28	German
Completion of Merger between Vivalis and Intercell to form Valneva M&A Activity	2013-05-28	English
Finalisation du processus de fusion entre Vivalis et Intercell pour former Valneva Delisting Announcement	2013-05-28	French
Merger between Intercell and Vivalis planned to complete on May 28, 2013 M&A Activity	2013-05-14	English
Fusion effective entre Intercell et Vivalis prévue pour le 28 mai 2013 Capital/Financing Update	2013-05-14	French
VIVALIS ANNONCE LA SIGNATURE D'UNE NOUVELLE LICENCE DE RECHERCHE AVEC UN LEADER MONDIAL DU VACCIN HUMAIN POUR L'UTILISATION DE LA LIGNEE CELLULAIRE EB66® Regulatory Filings	2013-05-06	French
VIVALIS ANNOUNCES A NEW EB66® CELL LINE RESEARCH LICENSE AGREEMENT WITH A MAJOR INTERNATIONAL HUMAN VACCINE CORPORATION Regulatory Filings	2013-05-06	English
VIVALIS : ACTIONS ET DROITS DE VOTE AVRIL 2013 Declaration of Voting Results & Voting Rights Announcements	2013-05-02	French
VIVALIS : MISE A DISPOSITION DU DOCUMENT DE REFERENCE 2012 Report Publication Announcement	2013-05-02	French
First Quarter 2013 Operating Income Increases 32% to €1.9 million Earnings Release Q1 2013	2013-04-25	English
Produits opérationnels en hausse de 32% à 1,9 M€ Earnings Release Q1 2013	2013-04-25	French
VIVALIS ANNOUNCES A NEW EB66® CELL LINE SERVICES AND LICENSE OPTION AGREEMENT WITH GLAXOSMITHKLINE Regulatory Filings	2013-04-08	English
VIVALIS ANNONCE UN NOUVEL ACCORD DE RECHERCHE AVEC OPTION DE LICENCE AVEC GLAXOSMITHLINE POUR L'UTILISATION DE LA LIGNEE CELLULAIRE EB66® M&A Activity	2013-04-08	French
VIVALIS : ACTIONS ET DROITS DE VOTE MARS 2013 Declaration of Voting Results & Voting Rights Announcements	2013-04-04	English
VIVALIS ANNOUNCES THE SUBMISSION OF THE FIRST NEW DRUG APPLICATION FOR AN H5N1 PANDEMIC INFLUENZA VACCINE PRODUCED IN THE EB66® CELL LINE Regulatory Filings	2013-04-02	English
VIVALIS ANNONCE LA SOUMISSION DE LA 1ERE DEMANDE D'AUTORISATION DE MISE SUR LE MARCHE (AMM) D'UN VACCIN CONTRE LA GRIPPE PANDEMIQUE H5N1 PRODUIT SUR LA LIGNEE CELLULAIRE EB66® Regulatory Filings	2013-04-02	French
VIVALIS PUBLIE SES RESULTATS 2012 Earnings Release FY 2012	2013-03-26	French
CONSOLIDATED 2012 FINANCIAL RESULTS Earnings Release FY 2012	2013-03-26	English
VIVALIS : NOUVELLE ETAPE DANS LE DEVELOPPEMENT DE LA LIGNEE CELLULAIRES EB66® Earnings Release FY 2012	2013-03-26	French
VIVALIS: EXPANDED DEVELOPMENT OF EB66® AS PART OF THE GLAXOSMITHKLINE INFLUENZA PROGRAM IN US Regulatory Filings	2013-03-26	English
VIVALIS : ACTIONS ET DROITS DE VOTE FÉVRIER 2013 Declaration of Voting Results & Voting Rights Announcements	2013-03-18	English
Les actionnaires de Vivalis SA et d'Intercell AG approuvent la fusion entre égaux proposée pour créer Valneva SE M&A Activity	2013-03-07	French
Vivalis SA and Intercell AG shareholders approved the proposed merger of equals to create Valneva SE M&A Activity	2013-03-07	English
L'Assemblée générale extraordinaire d'Intercell AG a approuvé la proposition de fusion avec Vivalis SA pour former Valneva SE M&A Activity	2013-02-28	French
Vivalis announces that the Intercell AG Extraordinary General Meeting has approved the proposed merger of equals with Vivalis SA to create Valneva SE AGM Information	2013-02-28	English
VIVALIS ANNOUNCES FOURTH QUARTER 2012 RESULTS Earnings Release FY 2012	2013-02-14	English
VIVALIS PUBLIE SES RESULTATS POUR LE 4EME TRIMESTRE 2012 Earnings Release Q4 2012	2013-02-14	French
VIVALIS ANNONCE LA SIGNATURE D'UNE NOUVELLE LICENCE DE RECHERCHE POUR L'UTILISATION DE SA LIGNEE CELLULAIRE EB66® AVEC UN LABORATOIRE VETERINAIRE NORD AMERICAIN Regulatory Filings	2013-02-12	French
VIVALIS ANNOUNCES A NEW EB66® CELL LINE RESEARCH LICENSE WITH A NORTH AMERICAN ANIMAL HEALTH VACCINE COMPANY Regulatory Filings	2013-02-12	English
VIVALIS SPECIAL AND COMBINED SHAREHOLDERS MEETINGS TO BE HELD MARCH 7, 2013 AGM Information	2013-02-11	English
VIVALIS ANNONCE LA TENUE DE SON ASSEMBLEE SPECIALE ET DE SON ASSEMBLEE GENERALE MIXTE LE 7 MARS 2013 AGM Information	2013-02-11	French
VIVALIS ANNONCE LA SIGNATURE D'UNE NOUVELLE LICENCE DE RECHERCHE POUR L'UTILISATION DE SA LIGNEE CELLULAIRE EB66® AVEC LE LABORATOIRE VETERINAIRE ITALIEN FATRO Regulatory Filings	2013-02-05	French
VIVALIS ANNOUNCES A NEW EB66® CELL LINE RESEARCH LICENSE WITH THE ITALIAN ANIMAL HEALTH VACCINE COMPANY FATRO Environmental & Social Information	2013-02-05	English
VIVALIS : ACTIONS ET DROIT DE VOTE JANVIER 2013 Declaration of Voting Results & Voting Rights Announcements	2013-02-05	English
Intercell and Vivalis provide update on the progress towards intended merger M&A Activity	2013-01-28	English
Point d'avancement sur le projet de fusion Intercell - Vivalis M&A Activity	2013-01-28	French
VIVALIS : MISE A DISPOSITION DU DOCUMENT E RELATIF AU PROJET DE FUSION ENTRE EGAUX ENTRE VIVALIS ET INTERCELL Report Publication Announcement	2013-01-24	English
AGENDA FINANCIER 2013 TRANSFERT DES ACTIONS VIVALIS AU COMPARTIMENT B D'EURONEXT Report Publication Announcement	2013-01-15	French
2013 FINANCIAL CALENDAR VIVALIS SHARES TRANSFERRED TO COMPARTMENT B OF NYSE EURONEXT Report Publication Announcement	2013-01-15	English
VIVALIS : CONTRAT DE LIQUIDITE BILAN SEMESTRIEL Transaction in Own Shares	2013-01-03	English
VIVALIS : ACTIONS ET DROIT DE VOTE DECEMBRE 2012 Declaration of Voting Results & Voting Rights Announcements	2013-01-03	English

Filings by year

2026 48 filings
2025 157 filings
2024 156 filings
2023 131 filings
2022 206 filings
2021 225 filings
2020 62 filings
2019 86 filings
2018 31 filings
2017 44 filings
2016 63 filings
2015 61 filings
2014 44 filings
2013 90 filings
2012 75 filings
2011 60 filings
2010 51 filings
2009 61 filings
2008 10 filings